Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma

Improved understanding of the contribution of eosinophils to various chronic inflammatory conditions, most notably allergic asthma, has encouraged development of monoclonal antibodies specifically targeting mediators and surface receptors involved in eosinophil expansion and activation. The pivotal...

Descripción completa

Detalles Bibliográficos
Autor principal: Roufosse, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897501/
https://www.ncbi.nlm.nih.gov/pubmed/29682504
http://dx.doi.org/10.3389/fmed.2018.00049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897501/
https://www.ncbi.nlm.nih.gov/pubmed/29682504
http://dx.doi.org/10.3389/fmed.2018.00049

Ejemplares similares